l-Gln and l-Ser suppress the d-galactosamine-induced IL-18 expression and hepatitis

Biochemical and Biophysical Research Communications

Volumn 372, Issue 4, 2008, Pages 688-690

  Komano, Torai ^a   Egashira, Yukari ^a   Sanada, Hiroo ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

d Galactosamine; ELISA; Hepatitis; IL 18; l Glutamine; l Serine; Liver injury; Real time PCR

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINO ACID; ASPARTATE AMINOTRANSFERASE; GALACTOSAMINE; GLYCINE; INTERLEUKIN 8; MESSENGER RNA; SERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS; LIVER INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ALANINE TRANSAMINASE; ANIMALS; DIET; DISEASE MODELS, ANIMAL; GALACTOSAMINE; GLUTAMINE; HEPATITIS, TOXIC; INTERLEUKIN-18; MALE; RATS; RATS, WISTAR; RNA, MESSENGER; SERINE; TRANSAMINASES;

ANIMALIA; RATTUS;

EID: 45449102623     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.05.114     Document Type: Article

References (20)

1. Keppler D., Lesch R., Reutter W., and Decker K. Experimental hepatitis induced by d-galactosamine. Exp. Mol. Pathol. 9 (1968) 279-290
2. Decker K., and Keppler D. Galactosamine induced liver injury. Prog. Liver Dis. 4 (1972) 183-199
3. Bauer C.H., Lukaschek R., and Reutter W.G. Studies on the Golgi apparatus. Cumulative inhibition of protein and glycoprotein secretion by d-galactosamine. Biochem. J. 142 (1974) 221-230
4. Hishinuma I., Nagakawa J., Hirota K., Miyamoto K., Tsukidate K., Yamanaka T., Katayama K., and Yamatsu I. Involvement of tumor necrosis factor-alpha in development of hepatic injury in galactosamine-sensitized mice. Hepatology 12 (1990) 1187-1191
5. Manabe A., Cheng C.C., Egashira Y., Ohta T., and Sanada H. Dietary wheat gluten alleviates the elevation of serum transaminase activities in d-galactosamine-injected rats. J. Nutr. Sci. Vitaminol. (Tokyo) 42 (1996) 121-132
6. Katayama T., Cheng C.C., Egashira Y., Ohta T., and Sanada H. Effect of dietary l-glutamine on the hepatotoxic action of d-galactosamine in rats. Biosci. Biotechnol. Biochem. 60 (1996) 1425-1429
7. Wang B., Ishihara M., Egashira Y., Ohta T., and Sanada H. Effects of various kinds of dietary amino acids on the hepatotoxic action of d-galactosamine in rats. Biosci. Biotechnol. Biochem. 63 (1999) 319-322
8. Stachlewitz R.F., Seabra V., Bradford B., Bradham C.A., Rusyn I., Germolec D., and Thurman R.G. Glycine and uridine prevent d-galactosamine hepatotoxicity in the rat: role of Kupffer cells. Hepatology 29 (1999) 737-745
9. Souba W.W. Glutamine: Physiology, Biochemistry and Nutrition in Critical Illness (1992), R.G. Landes Company, Austin
10. Evans M.E., Jones D.P., and Ziegler T.R. Glutamine prevents cytokine-induced apoptosis in human colonic epithelial cells. J. Nutr. 133 (2003) 3065-3071
11. Souba W.W., Herskowitz K., Klimberg V.S., Salloum R.M., Plumley D.A., Flynn T.C., and Copeland III E.M. The effects of sepsis and endotoxemia on gut glutamine metabolism. Ann. Surg. 211 (1990) 543-549
12. Yoshida T., Abe K., Ikeda T., Matsushita T., Wake K., Sato T., Sato T., and Inoue H. Inhibitory effect of glycyrrhizin on lipopolysaccharide and d-galactosamine-induced mouse liver injury. Eur. J. Pharmacol. 576 (2007) 136-142
13. Reeves P.G., Nielsen F.H., and Fahey Jr. G.C. AIN-93 purified diets for laboratory rodents: final report of the American institute of nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123 (1993) 1939-1951
14. Tsutsui H., Matsui K., Okamura H., and Nakanishi K. Pathophysiological roles of interleukin-18 in inflammatory liver diseases. Immunol. Rev. 174 (2000) 192-209
15. Tanaka T., Tsutsui H., Yoshimoto T., Kotani M., Matsumoto M., Fujita A., Wang W., Higa S., Koshimoto T., Nakanishi K., and Suemura M. Interleukin-18 is elevated in the sera from patients with atopic dermatitis and from atopic dermatitis model mice, NC/Nga. Int. Arch. Allergy Immunol. 125 (2001) 236-240
16. Lee K.S., Kim S.R., Park S.J., Min K.H., Lee K.Y., Jin S.M., Yoo W.H., and Lee Y.C. Antioxidant down-regulates interleukin-18 expression in asthma. Mol. Pharmacol. 70 (2006) 1184-1193
17. Finotto S., Siebler J., Hausding M., Schipp M., Wirtz S., Klein S., Protschka M., Doganci A., Lehr H.A., Trautwein C., Khosravi-Far R., Strand D., Lohse A., Galle P.R., Blessing M., and Neurath M.F. Severe hepatic injury in interleukin 18 (IL-18) transgenic mice: a key role for IL-18 in regulating hepatocyte apoptosis in vivo. Gut 53 (2004) 392-400
18. Spahr L., Garcia I., Bresson-Hadni S., Rubbia-Brandt L., Guler R., Olleros M., Chvatchko Y., and Hadengue A. Circulating concentrations of interleukin-18, interleukin-18 binding protein, and gamma interferon in patients with alcoholic hepatitis. Liver Int. 24 (2004) 582-587
19. Murata K., Yamamoto N., Kawakita T., Saito Y., Yamanaka Y., Sugimoto K., Shiraki K., Nakano T., and Tameda Y. Up-regulation of IL-18 by interferon alpha-2b/ribavirin combination therapy induces an anti-viral effect in patients with chronic hepatitis C. Hepatogastroenterology 52 (2005) 547-551
20. Vecchiet J., Falasca K., Cacciatore P., Zingariello P., Dalessandro M., Marinopiccoli M., D'Amico E., Palazzi C., Petrarca C., Conti P., Pizzigallo E., and Guagnano M.T. Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C virus infection and non-alcoholic fatty liver disease. Ann. Clin. Lab. Sci. 35 (2005) 415-422